Literature DB >> 19117399

Arenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola.

Ratnakar N Asolkar1, Kelle C Freel, Paul R Jensen, William Fenical, Tamara P Kondratyuk, Eun-Jung Park, John M Pezzuto.   

Abstract

Three new cyclohexadepsipeptides, arenamides A-C (1-3), were isolated from the fermentation broth of a marine bacterial strain identified as Salinispora arenicola. The planar structures of these compounds were assigned by detailed interpretation of NMR and MS/MS spectroscopic data. The absolute configurations of the amino acids, and those of the chiral centers on the side chain, were established by application of the Marfey and modified Mosher methods. The effect of arenamides A and B on NFkappaB activity was studied with stably transfected 293/NFkappaB-Luc human embryonic kidney cells induced by treatment with tumor necrosis factor (TNF). Arenamides A (1) and B (2) blocked TNF-induced activation in a dose- and time-dependent manner with IC(50) values of 3.7 and 1.7 microM, respectively. In addition, the compounds inhibited nitric oxide (NO) and prostaglandin E(2) (PGE(2)) production with lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. Moderate cytotoxicity was observed with the human colon carcinoma cell line HCT-116, but no cytotoxic effect was noted with cultured RAW cells. Taken together, these data suggest that the chemoprevention and anti-inflammatory characteristics of arenamides A and B warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117399      PMCID: PMC2837138          DOI: 10.1021/np800617a

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  20 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Microcolins A and B, new immunosuppressive peptides from the blue-green alga Lyngbya majuscula.

Authors:  F E Koehn; R E Longley; J K Reed
Journal:  J Nat Prod       Date:  1992-05       Impact factor: 4.050

3.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

4.  Mulberry anthracnose antagonists (iturins) produced by Bacillus amyloliquefaciens RC-2.

Authors:  Syuntaro Hiradate; Shigenobu Yoshida; Hajime Sugie; Hiroshi Yada; Yoshiharu Fujii
Journal:  Phytochemistry       Date:  2002-11       Impact factor: 4.072

5.  Vinylamycin, a new depsipeptide antibiotic, from Streptomyces sp.

Authors:  M Igarashi; T Shida; Y Sasaki; N Kinoshita; H Naganawa; M Hamada; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1999-10       Impact factor: 2.649

6.  Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro.

Authors:  Martha Lappas; Michael Permezel; Harry M Georgiou; Gregory E Rice
Journal:  Biol Reprod       Date:  2002-08       Impact factor: 4.285

7.  Biosynthesis and structures of cyclomarins and cyclomarazines, prenylated cyclic peptides of marine actinobacterial origin.

Authors:  Andrew W Schultz; Dong-Chan Oh; John R Carney; R Thomas Williamson; Daniel W Udwary; Paul R Jensen; Steven J Gould; William Fenical; Bradley S Moore
Journal:  J Am Chem Soc       Date:  2008-03-11       Impact factor: 15.419

8.  Beauverolides L and La from Beauveria tenella and Paecilomyces fumosoroseus.

Authors:  A Jegorov; P Sedmera; V Matha; P Simek; H Zahradnícková; Z Landa; J Eyal
Journal:  Phytochemistry       Date:  1994-11       Impact factor: 4.072

Review 9.  Resveratrol: a multitargeted agent for age-associated chronic diseases.

Authors:  Kuzhuvelil B Harikumar; Bharat B Aggarwal
Journal:  Cell Cycle       Date:  2008-02-15       Impact factor: 4.534

Review 10.  Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation.

Authors:  Hun-Taeg Chung; Byung-Min Choi; Young-Guen Kwon; Young-Myeong Kim
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

View more
  26 in total

1.  Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

Authors:  Juma Hoshino; Eun-Jung Park; Tamara P Kondratyuk; Laura Marler; John M Pezzuto; Richard B van Breemen; Shunyan Mo; Yongchao Li; Mark Cushman
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

Review 2.  The bacterial instrument as a promising therapy for colon cancer.

Authors:  Atieh Yaghoubi; Majid Khazaei; Amir Avan; Seyed Mahdi Hasanian; Saman Soleimanpour
Journal:  Int J Colorectal Dis       Date:  2020-03-04       Impact factor: 2.571

3.  Genomic insights into specialized metabolism in the marine actinomycete Salinispora.

Authors:  Anne-Catrin Letzel; Jing Li; Gregory C A Amos; Natalie Millán-Aguiñaga; Joape Ginigini; Usama R Abdelmohsen; Susana P Gaudêncio; Nadine Ziemert; Bradley S Moore; Paul R Jensen
Journal:  Environ Microbiol       Date:  2017-08-14       Impact factor: 5.491

Review 4.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

5.  Fijimycins A-C, three antibacterial etamycin-class depsipeptides from a marine-derived Streptomyces sp.

Authors:  Peng Sun; Katherine N Maloney; Sang-Jip Nam; Nina M Haste; Ritesh Raju; William Aalbersberg; Paul R Jensen; Victor Nizet; Mary E Hensler; William Fenical
Journal:  Bioorg Med Chem       Date:  2011-06-26       Impact factor: 3.641

Review 6.  The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery.

Authors:  Paul R Jensen; Bradley S Moore; William Fenical
Journal:  Nat Prod Rep       Date:  2015-05       Impact factor: 13.423

Review 7.  Antitumor compounds from marine actinomycetes.

Authors:  Carlos Olano; Carmen Méndez; José A Salas
Journal:  Mar Drugs       Date:  2009-06-11       Impact factor: 5.118

Review 8.  Marine antitumor drugs: status, shortfalls and strategies.

Authors:  Ira Bhatnagar; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2010-10-15       Impact factor: 5.118

Review 9.  Colorectal cancer treatment using bacteria: focus on molecular mechanisms.

Authors:  Sara Ebrahimzadeh; Hossein Ahangari; Alireza Soleimanian; Kamran Hosseini; Vida Ebrahimi; Tohid Ghasemnejad; Saiedeh Razi Soofiyani; Vahideh Tarhriz; Shirin Eyvazi
Journal:  BMC Microbiol       Date:  2021-07-19       Impact factor: 3.605

10.  Cell survival and apoptosis signaling as therapeutic target for cancer: marine bioactive compounds.

Authors:  Senthilkumar Kalimuthu; Kim Se-Kwon
Journal:  Int J Mol Sci       Date:  2013-01-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.